SIMCYP

Welcome to the Brand page for “SIMCYP”, which is offered here for Computer software, computer software for the conducting of pharmacokinetic and pharmacodynamic simulations of medicines and their effect on the human body, computer software for utilising demographic, physiologic, and genomic databases for the creation and development of algorithms allowing researchers to take into account patient variability, computer software for the production of drug effects on a virtual patient population, computer software which allows pharmaceutical product developers to identify potential patients and groups of individuals which may be at extreme risk to adverse reaction to particular medicines or combinations; pharmaceutical analysis computer software; computer software that uses in vitro data from human tissues to predict metabolism, interactions and kinetic behaviour of drugs/chemicals in vivo (whole human);color is not claimed as a feature of the mark.;scientific consultancy services in the field of pharmaceutical product development, pharmaceutical research, pharmaceutical drug research and development, virtual testing of new pharmaceutical drugs and products by means of computer simulation; scientific consultancy services employing pharmaceutical analysis software that uses in vitro data from human tissues to predict the metabolism, interactions, and kinetic behaviour of drugs/chemicals in vivo (whole human);.

Its status is currently believed to be active. Its class is unavailable. “SIMCYP” is believed to be currently owned by “Simcyp Limited”.